Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    GeneDx Corp.

    NASDAQ: WGS · Real-Time Price · USD
    64.58
    -1.79 (-2.70%)
    At close: Jun 13, 2025, 3:59 PM
    64.30
    -0.43%
    After-hours: Jun 13, 2025, 05:59 PM EDT

    GeneDx Statistics

    Share Statistics

    GeneDx has 28.53M shares outstanding. The number of shares has increased by 7.33% in one year.

    Shares Outstanding

    n/a
    		 28.53M

    Shares Change (YoY)

    n/a
    		 7.33%

    Shares Change (QoQ)

    n/a
    		 2.17%

    Owned by Institutions (%)

    n/a
    		 86.84%

    Shares Floating

    n/a
    		 25.03M

    Failed to Deliver (FTD) Shares

    n/a
    		 25,076

    FTD / Avg. Volume

    n/a
    		 2.3%

    Short Selling Information

    The latest short interest is 3.64M, so 12.74% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.64M

    Short % of Shares Out

    n/a
    		 12.74%

    Short % of Float

    n/a
    		 31.63%

    Short Ratio (days to cover)

    n/a
    		 4.27

    Valuation Ratios

    The PE ratio is -39.53 and the forward PE ratio is 32.65. GeneDx's PEG ratio is 0.54.

    PE Ratio

    n/a
    		 -39.53

    Forward PE

    n/a
    		 32.65

    PS Ratio

    n/a
    		 6.77

    Forward PS

    n/a
    		 2.7

    PB Ratio

    n/a
    		 8.43

    P/FCF Ratio

    n/a
    		 -60.81

    PEG Ratio

    n/a
    		 0.54
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for GeneDx.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.61, with a Debt / Equity ratio of 0.47.

    Current Ratio

    n/a
    		 3.61

    Quick Ratio

    n/a
    		 3.42

    Debt / Equity

    n/a
    		 0.47

    Debt / EBITDA

    n/a
    		 -5

    Debt / FCF

    n/a
    		 -3.42

    Interest Coverage

    n/a
    		 7.66

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $305,450

    Profits Per Employee

    n/a
    		 $-52,286

    Employee Count

    n/a
    		 1,000

    Asset Turnover

    n/a
    		 0.73

    Inventory Turnover

    n/a
    		 10.43

    Taxes

    Income Tax

    n/a
    		 -343K

    Effective Tax Rate

    n/a
    		 0.65%

    Stock Price Statistics

    The stock price has increased by 124.39% in the last 52 weeks. The beta is 2.01, so GeneDx's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.01

    52-Week Price Change

    n/a
    		 124.39%

    50-Day Moving Average

    n/a
    		 78.05

    200-Day Moving Average

    n/a
    		 73.1

    Relative Strength Index (RSI)

    n/a
    		 39.87

    Average Volume (20 Days)

    n/a
    		 1,089,690

    Income Statement

    In the last 12 months, GeneDx had revenue of 305.45M and earned -52.29M in profits. Earnings per share was -1.94.

    Revenue

    n/a
    		 305.45M

    Gross Profit

    n/a
    		 194.4M

    Operating Income

    n/a
    		 -23.21M

    Net Income

    n/a
    		 -52.29M

    EBITDA

    n/a
    		 -23.21M

    EBIT

    n/a
    		 -55.66M

    Earnings Per Share (EPS)

    n/a
    		 -1.94
    Full Income Statement

    Balance Sheet

    The company has 85.21M in cash and 116.17M in debt, giving a net cash position of -30.96M.

    Cash & Cash Equivalents

    n/a
    		 85.21M

    Total Debt

    n/a
    		 116.17M

    Net Cash

    n/a
    		 -30.96M

    Retained Earnings

    n/a
    		 -1.35B

    Total Assets

    n/a
    		 446.43M

    Working Capital

    n/a
    		 156.28M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -28.5M and capital expenditures -5.49M, giving a free cash flow of -33.99M.

    Operating Cash Flow

    n/a
    		 -28.5M

    Capital Expenditures

    n/a
    		 -5.49M

    Free Cash Flow

    n/a
    		 -33.99M

    FCF Per Share

    n/a
    		 -1.26
    Full Cash Flow Statement

    Margins

    Gross margin is 63.64%, with operating and profit margins of -7.6% and -17.12%.

    Gross Margin

    n/a
    		 63.64%

    Operating Margin

    n/a
    		 -7.6%

    Pretax Margin

    n/a
    		 -17.23%

    Profit Margin

    n/a
    		 -17.12%

    EBITDA Margin

    n/a
    		 -7.6%

    EBIT Margin

    n/a
    		 -7.6%

    FCF Margin

    n/a
    		 -11.13%

    Dividends & Yields

    WGS does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for WGS is $80, which is 23.9% higher than the current price. The consensus rating is "Strong Buy".

    Price Target

    n/a
    		 $80

    Price Target Difference

    n/a
    		 23.9%

    Analyst Consensus

    n/a
    		 Strong Buy

    Analyst Count

    n/a
    		 8
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on May 4, 2023. It was a backward split with a ratio of 1:33.

    Last Split Date

    n/a
    		 May 4, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:33

    Scores

    Altman Z-Score

    n/a
    		 2.98

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist